Special Advertising

Pivotal Therapeutics Inc. (PVO:CNX) Stock Quote

Detailed Quote for Pivotal Therapeutics Inc. (PVO:CNX)
$ 0.19 0.00 (0.00%) Volume: 6.5k 3:53 PM EDT Apr 17, 2014
Today 5d 1m 3m 1y more
Last Price
0.19
Change $
Change %
Tick
  
Bid
0.17
Bid Size
2,000
Ask
0.19
Ask Size
22,000
Open
0.17
High
0.19
Low
0.15
Prev Close
0.19
Last Trade
04/17/14
Volume
6.5k
52 Wk Hi
0.24
52 Wk Low
0.03
Market Cap
17.46m
Ex-Div Date
N/A
Div Rate
N/A
Yield
N/A
Shares
91,916,277
EPS (TTM)
-0.04
PE Ratio
N/A
Exchange
CSE
News and Media for Pivotal Therapeutics Inc. (PVO:CNX)
Sector News | Topic News
News for Pivotal Therapeutics Inc. (PVO:CNX)
Tue, Apr 08, 2014
2:58 PM Pivotal Therapeutics grants incentive stock options - Canada Newswire
2:58 PM Pivotal Therapeutics grants incentive stock options - PR Newswire
Fri, Mar 14, 2014
5:40 PM Pivotal Therapeutics grants incentive stock options - Canada Newswire
5:40 PM Pivotal Therapeutics grants incentive stock options - PR Newswire
Mon, Mar 10, 2014
9:40 AM Pivotal Therapeutics appoints pharmaceutical executive James Connolly to Board of Directors - Canada Newswire
9:40 AM Pivotal Therapeutics appoints pharmaceutical executive James Connolly to Board of Directors - PR Newswire
Tue, Mar 04, 2014
9:42 AM Pivotal Therapeutics Closes Financing; Receives Over CDN $7.7 Million to Further VASCAZEN\u00AE Commercialization - PR Newswire
8:00 AM Pivotal Therapeutics closes financing; receives over CDN $7.7 million to further VASCAZEN\u00AE commercialization - PR Newswire
8:00 AM Pivotal Therapeutics closes financing; receives over CDN $7.7 million to further VASCAZEN\u00AE commercialization - Canada Newswire
Wed, Jan 29, 2014
1:06 PM Pivotal Therapeutics Announces Notice of Allowance for U.S. Patent on its Unique 6:1 EPA:DHA Formulation - PR Newswire
12:04 PM IIROC Trade Resumption - PVO - Canada Newswire
11:50 AM Pivotal Therapeutics announces Notice of Allowance for U.S. Patent on its unique 6:1 EPA:DHA Formulation - Canada Newswire
11:50 AM Pivotal Therapeutics announces Notice of Allowance for U.S. Patent on its unique 6:1 EPA:DHA Formulation - PR Newswire
11:45 AM IIROC Trading Halt - PVO (all issues) - Canada Newswire
Fri, Nov 29, 2013
4:38 PM Pivotal Therapeutics Announces Third Quarter 2013 Financial Results - Canada Newswire
4:38 PM Pivotal Therapeutics Announces Third Quarter 2013 Financial Results - PR Newswire
Fri, Nov 01, 2013
9:02 PM Pivotal Therapeutics Inc. Announces Extension of Debt Financing - Canada Newswire
9:02 PM Pivotal Therapeutics Inc. Announces Extension of Debt Financing - PR Newswire
Wed, Oct 30, 2013
5:45 PM John P. Nicholson Jr., MD, MBA, FACC Appointed to Pivotal Board of Directors - Canada Newswire
5:45 PM John P. Nicholson Jr., MD, MBA, FACC Appointed to Pivotal Board of Directors - PR Newswire
More News for PVO:CNX >>

Tags for Pivotal Therapeutics Inc.

Research stocks or mutual funds related to Pivotal Therapeutics Inc. by keywords or tags. Find companies that have a similar focus to PVO:CNX. The keywords below have been associated to PVO:CNX by either user submission or electronic means.